TP53 and breast carcinoma: Recent clinical studies suggest that BRCA1+TP53+ TNBC cases had better OS chances than BRCA1−TP53− cases and, in fact, the survival ability of breast cancer patients goes down when both BRCA1 and TP53 are affected (Kim et al., 2016).